BRAF and neoplasm: To exclude the possibility that melanoma cells become more sensitive to tumor killing in general in the absence of Mi-2β, BRafV600E/Ptennull melanoma cells with different Mi-2β status were stimulated with BRaf inhibitor, PLX4032.